Related Experiment Video
Updated: Jun 24, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Genetic epidemiology. Psoriatic arthritis
1Arthritis Rheumatism Campaign Epidemiology Research Unit, University of Manchester, UK. ABarton@fs1.ser.man.ac.uk
Arthritis Research
|July 11, 2002
Summary
Psoriatic arthritis may be a distinct condition, not just co-occurring psoriasis and inflammatory arthritis. This review examines evidence for unique genetic factors contributing to psoriatic arthritis development.
Area of Science:
- Rheumatology
- Genetics
- Dermatology
Background:
- Psoriatic arthritis (PsA) is debated as a distinct entity.
- Some propose it's merely psoriasis co-occurring with inflammatory arthritis.
- Distinct conditions often possess unique etiological factors.
Purpose of the Study:
- To review the evidence for genetic susceptibility factors specific to psoriatic arthritis.
- To explore if PsA has unique genetic underpinnings beyond psoriasis and general inflammatory arthritis.
Main Methods:
- Literature review focusing on genetic studies related to psoriatic arthritis.
- Analysis of etiological factors, distinguishing between general and specific susceptibility.
Main Results:
- Evidence suggests distinct genetic factors may contribute to psoriatic arthritis.
- These factors differentiate PsA from the independent occurrence of psoriasis and inflammatory arthritis.
Conclusions:
- The existence of psoriatic arthritis as a distinct clinical entity is supported by potential unique genetic susceptibility factors.
- Further research into these genetic factors is warranted to understand PsA's etiology.
Related Concept Videos
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...